Cuneyt Tamam
Research Subjects
Research Interests
Cuneyt Tamam has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Duzgun Yildirim
Kasimpasa Military Hospital, Department of Radiology, Istanbul, Turkey
5 shared publications Serdar Hira
5 shared publicationsBaki Ekci
4 shared publicationsMehmet Mulazimoglu
Department of Orthopedics and Traumatology, Kasimpasa Military Hospital, Istanbul, Turkey
4 shared publicationsBengi Gurses
3 shared publicationsDuzgun Yildirim
Radiology, Kasimpasa Military Hospital
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1430-1441
Baseline 18F-FDG PET/CT-derived metabolic parameters and intratumoral heterogeneity in relation to survival in bone sarcomas
Background/aim: This study assessed correlations between intratumoral heterogeneity, survival outcomes, and baseline 18F-FDG PET/ CT-derived semiquantitative metabolic parameters and histological subtype in patients with bone sarcomas. Materials and methods: We retrospectively analyzed 44 patients with biopsy-proven bone sarcomas who underwent baseline 18F-FDG PET/CT before treatment. Total lesion glycolysis, metabolic tumor volume, heterogeneity indices (HI1, HI2, HI3), and semiquantitative standardized uptake parameters (SUVmax, SUVmean, SUVpeak, and SUVmin), all derived from the primary tumor, were examined. SUVmin and SUVmax AUCs were compared using the DeLong test. Kaplan–Meier survival analysis, Cox regression, correlation analysis, and ROC analysis were used to assess associations with clinicopathological characteristics, survival outcomes, and metastatic status. Results: Tumor volume and diameter differed according to vital status, being higher in patients who died during follow-up (p = 0.024 and p = 0.032, respectively). Osteosarcoma showed nominally higher SUVmax, SUVmin, SUVmean, and HI1 values than Ewing sarcoma. HI2 showed a strong inverse correlation with tumor volume (r = –0.80, p < 0.001) but was not significantly associated with AJCC stage (p = 0.26). SUVmin was nominally higher in deceased patients and had the highest AUC for discriminating vital status (AUC: 0.713, sensitivity: 80%, specificity: 69%, p = 0.014); the SUVmin and SUVmax ROC curves did not differ significantly (DeLong p = 0.165). Metabolic parameters did not significantly discriminate metastatic from nonmetastatic disease (p > 0.05 for all). Conclusion: Tumor burden, stage, and survival in bone sarcomas correlated strongly with baseline 18F-FDG PET/CT-derived metabolic and heterogeneity characteristics. SUVmin showed the highest discriminative ability for vital status among the tested parameters but did not significantly outperform SUVmax in ROC comparisons, highlighting the limitations of single-voxel measures. These data support the implementation of multiparametric PET/CT for more granular risk stratification and biological profiling, but further investigation in broader prospective cohorts is required.
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1430-1441
Open AccessBaseline 18F-FDG PET/CT-derived metabolic parameters and intratumoral heterogeneity in relation to survival in bone sarcomas
Background/aim: This study assessed correlations between intratumoral heterogeneity, survival outcomes, and baseline 18F-FDG PET/ CT-derived semiquantitative metabolic parameters and histological subtype in patients with bone sarcomas. Materials and methods: We retrospectively analyzed 44 patients with biopsy-proven bone sarcomas who underwent baseline 18F-FDG PET/CT before treatment. Total lesion glycolysis, metabolic tumor volume, heterogeneity indices (HI1, HI2, HI3), and semiquantitative standardized uptake parameters (SUVmax, SUVmean, SUVpeak, and SUVmin), all derived from the primary tumor, were examined. SUVmin and SUVmax AUCs were compared using the DeLong test. Kaplan–Meier survival analysis, Cox regression, correlation analysis, and ROC analysis were used to assess associations with clinicopathological characteristics, survival outcomes, and metastatic status. Results: Tumor volume and diameter differed according to vital status, being higher in patients who died during follow-up (p = 0.024 and p = 0.032, respectively). Osteosarcoma showed nominally higher SUVmax, SUVmin, SUVmean, and HI1 values than Ewing sarcoma. HI2 showed a strong inverse correlation with tumor volume (r = –0.80, p < 0.001) but was not significantly associated with AJCC stage (p = 0.26). SUVmin was nominally higher in deceased patients and had the highest AUC for discriminating vital status (AUC: 0.713, sensitivity: 80%, specificity: 69%, p = 0.014); the SUVmin and SUVmax ROC curves did not differ significantly (DeLong p = 0.165). Metabolic parameters did not significantly discriminate metastatic from nonmetastatic disease (p > 0.05 for all). Conclusion: Tumor burden, stage, and survival in bone sarcomas correlated strongly with baseline 18F-FDG PET/CT-derived metabolic and heterogeneity characteristics. SUVmin showed the highest discriminative ability for vital status among the tested parameters but did not significantly outperform SUVmax in ROC comparisons, highlighting the limitations of single-voxel measures. These data support the implementation of multiparametric PET/CT for more granular risk stratification and biological profiling, but further investigation in broader prospective cohorts is required.
- 7 September 2021
- Published by Academician Publishing
Temel Akupunktur Noktaları
Bu kitapla; geleneksel akupunktur uygulayanlara, geleneksel Batı eğitimi almış tıbbi akupunktur uygulayanlara, akupunktur öğrencilerine ve tüm tıp doktorlarına erişmeyi amaçlamaktayız. Zengin resim ve şekillerle desteklenerek anlatılmış konuların daha iyi anlaşılacağını ve pratikte kullanım kolaylığı sağlayacağını ümit ediyoruz. Kitap anlaşılabilir bir dille yazılmış olsa da bazı terimlerin Türkçe daha iyi kavranabilmesi için bazı değişiklikler yapıldı. Eserin tüm meslektaşlarımıza pratik uygulamalarında katkı sunacak bir başucu kitabı olacağını düşünüyoruz.
- 7 September 2021
- Published by Academician Publishing
Temel Akupunktur Noktaları
Bu kitapla; geleneksel akupunktur uygulayanlara, geleneksel Batı eğitimi almış tıbbi akupunktur uygulayanlara, akupunktur öğrencilerine ve tüm tıp doktorlarına erişmeyi amaçlamaktayız. Zengin resim ve şekillerle desteklenerek anlatılmış konuların daha iyi anlaşılacağını ve pratikte kullanım kolaylığı sağlayacağını ümit ediyoruz. Kitap anlaşılabilir bir dille yazılmış olsa da bazı terimlerin Türkçe daha iyi kavranabilmesi için bazı değişiklikler yapıldı. Eserin tüm meslektaşlarımıza pratik uygulamalarında katkı sunacak bir başucu kitabı olacağını düşünüyoruz.
- 1 January 2021
- Published by Academician Publishing
Psikonöroimmünoloji Yöntem ve İzlenceler
Birçok disiplini kapsayan bir alan olan psikonöroimmülojide (PNI) biyopsikososyal modeller sağlık ve hastalıkların anlaşılmasında giderek merkezi bir konu halini almıştır. Böyle bir anlayış kişiye yönelik ve sistemik tıbbın geliştirilmesi için daha doğru bir tanıkonulması ve daha iyi terapötiklerin eldesinde bize olanak sağlayacaktır.
- 1 January 2021
- Published by Academician Publishing
Psikonöroimmünoloji Yöntem ve İzlenceler
Birçok disiplini kapsayan bir alan olan psikonöroimmülojide (PNI) biyopsikososyal modeller sağlık ve hastalıkların anlaşılmasında giderek merkezi bir konu halini almıştır. Böyle bir anlayış kişiye yönelik ve sistemik tıbbın geliştirilmesi için daha doğru bir tanıkonulması ve daha iyi terapötiklerin eldesinde bize olanak sağlayacaktır.
- 19 December 2018
- Published by Joint Diseases and Related Surgery in Eklem Hastalik Cerrahisi
- Vol. 29 (3) , 184-188
Prognostic significance of maximum standardized uptake value on 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas
Objectives: This study aims to evaluate the prognostic significance of maximum standardized uptake value (SUVmax)on F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography ((18)FDG-PET/CT) for bone sarcoma. Patients and methods: We retrospectively evaluated 34 patients (24 males, 10 females; mean age 36.6 +/- 24.2 years; range, 5 to 77 years) with pathologically proven bone sarcoma who underwent (18)FDG-PET/CT for initial staging between September 2013 and September 2017. SUVmax of primary lesions were measured. Cumulative survival rate was calculated to evaluate the prognostic value of (18)FDG-PET/CT findings. Survival duration was defined as the elapsed duration from the date of pre-treatment (18)FDG-PET/CT scanning until the date of the final examination before the date of death. Results: The cut-off value for SUVmax in the definition of progression was 8. Mean SUVmax of the progressive group was statistically significantly higher than the non-progressive group. Distant metastases were present in 14 (41.1%) cases. Mortality and cumulative survival rates were 14.7% and 79.1 +/- 0.08%, respectively. Conclusion: Semiquantitative estimation of primary tumor metabolic activity in terms of baseline SUVmax using (18)FDG-PET/CT can predict the overall survival of patients with bone sarcoma.
- 19 December 2018
- Published by Joint Diseases and Related Surgery in Eklem Hastalik Cerrahisi
- Vol. 29 (3) , 184-188
Prognostic significance of maximum standardized uptake value on 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas
Objectives: This study aims to evaluate the prognostic significance of maximum standardized uptake value (SUVmax)on F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography ((18)FDG-PET/CT) for bone sarcoma. Patients and methods: We retrospectively evaluated 34 patients (24 males, 10 females; mean age 36.6 +/- 24.2 years; range, 5 to 77 years) with pathologically proven bone sarcoma who underwent (18)FDG-PET/CT for initial staging between September 2013 and September 2017. SUVmax of primary lesions were measured. Cumulative survival rate was calculated to evaluate the prognostic value of (18)FDG-PET/CT findings. Survival duration was defined as the elapsed duration from the date of pre-treatment (18)FDG-PET/CT scanning until the date of the final examination before the date of death. Results: The cut-off value for SUVmax in the definition of progression was 8. Mean SUVmax of the progressive group was statistically significantly higher than the non-progressive group. Distant metastases were present in 14 (41.1%) cases. Mortality and cumulative survival rates were 14.7% and 79.1 +/- 0.08%, respectively. Conclusion: Semiquantitative estimation of primary tumor metabolic activity in terms of baseline SUVmax using (18)FDG-PET/CT can predict the overall survival of patients with bone sarcoma.
- 1 November 2018
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 9 (6) , 547-550
The efficiency of prolotherapy in lateral epicondylitis
Aim Lateral epicondylitis, is an overuse syndrome of the forearm extensor muscles. In this study, we aimed to investigate the effect of prolotherapy in patients with lateral epicondylitis in terms of pain, and function. Methods This retrospective study comprised 23 consecutive patients above 18 years of age, who were diagnosed as lateral epicondylitis. Demographic data, VAS and DASH score were derived from chart review. Results Our findings revealed that prolotherapy treatment lead to statistically significant improvement in pain and function. Conclusion Prolotherapy has been proposed as a potential therapy for chronic tendinitis and believed to produce a controlled inflammatory response and to stimulate an adequate fibroblastic proliferation and connective tissue repair Pain reduction is also hypothesized to be related to the elimination of nerve fibers that are associated with neovessels or collagen fibril disruption and subsequent healing response. Discussion Prolotherapy is a safe and effective alternative option for patients with refractory lateral epicondylitis.
- 1 November 2018
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 9 (6) , 547-550
The efficiency of prolotherapy in lateral epicondylitis
Aim Lateral epicondylitis, is an overuse syndrome of the forearm extensor muscles. In this study, we aimed to investigate the effect of prolotherapy in patients with lateral epicondylitis in terms of pain, and function. Methods This retrospective study comprised 23 consecutive patients above 18 years of age, who were diagnosed as lateral epicondylitis. Demographic data, VAS and DASH score were derived from chart review. Results Our findings revealed that prolotherapy treatment lead to statistically significant improvement in pain and function. Conclusion Prolotherapy has been proposed as a potential therapy for chronic tendinitis and believed to produce a controlled inflammatory response and to stimulate an adequate fibroblastic proliferation and connective tissue repair Pain reduction is also hypothesized to be related to the elimination of nerve fibers that are associated with neovessels or collagen fibril disruption and subsequent healing response. Discussion Prolotherapy is a safe and effective alternative option for patients with refractory lateral epicondylitis.
- Open Access
- 1 January 2018
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 43 (Ek 1) , 70-74
Effect of hyperosmolar dextrose injections for treatment of Achilles tendinopathy
Purpose: Achilles tendinopathy is a degenerative, not an inflammatory, condition. It is one of the most frequently injured tendons in the human body despite its strength, due to repetitive strain acting on the tendon. Hyperosmolar dextrose injections also called prolotherapy, is a regenerative injection technique using stimulation of regenerative processes for treatment of chronic musculoskeletal conditions. The aim of study was to investigate the effect of prolotherapy in patients with non-insertional Achilles tendinopathy in terms of pain. Materials and Methods: This retrospective study is comprised of 18 consecutive patients above 18 years of age, who were diagnosed as Achilles tendinopathy. Visual analogue scale (VAS) was used to assess pain intensity in the last 24 h. Injections were applied to tender points in the subcutaneous tissues adjacent to the affected tendon. All evaluations were done before treatment, at 4 weeks and 12 weeks after treatment. Results: The study sample consisted of 18 adults (12 female and 6 male). Subjects' ages ranged from 18 to 52 years, with a mean age of 34.89 +/- SD 12.04 years. A statistically significant improvement in the VAS scale was demonstrated. Conclusion: Hyperosomolar dextrose injections, irrespective of dextrose concentration is an efficient alternative regenerative treatment modality for achilles tendinopathy. Thus, it should be considered as a treatment option for chronic musculoskeletal conditions, particularly tendinopaties.
- 1 January 2018
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 43 (Ek 1) , 70-74
Open AccessEffect of hyperosmolar dextrose injections for treatment of Achilles tendinopathy
Purpose: Achilles tendinopathy is a degenerative, not an inflammatory, condition. It is one of the most frequently injured tendons in the human body despite its strength, due to repetitive strain acting on the tendon. Hyperosmolar dextrose injections also called prolotherapy, is a regenerative injection technique using stimulation of regenerative processes for treatment of chronic musculoskeletal conditions. The aim of study was to investigate the effect of prolotherapy in patients with non-insertional Achilles tendinopathy in terms of pain. Materials and Methods: This retrospective study is comprised of 18 consecutive patients above 18 years of age, who were diagnosed as Achilles tendinopathy. Visual analogue scale (VAS) was used to assess pain intensity in the last 24 h. Injections were applied to tender points in the subcutaneous tissues adjacent to the affected tendon. All evaluations were done before treatment, at 4 weeks and 12 weeks after treatment. Results: The study sample consisted of 18 adults (12 female and 6 male). Subjects' ages ranged from 18 to 52 years, with a mean age of 34.89 +/- SD 12.04 years. A statistically significant improvement in the VAS scale was demonstrated. Conclusion: Hyperosomolar dextrose injections, irrespective of dextrose concentration is an efficient alternative regenerative treatment modality for achilles tendinopathy. Thus, it should be considered as a treatment option for chronic musculoskeletal conditions, particularly tendinopaties.
- 1 July 2017
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 8 (4) , 270-273
Evaluation of serum levels of osteopontin and bone sialoprotein in female patients with tendinopathy
Aim The pathogenesis of tendinopathy remains unclear. Small integrin-binding ligand N-linked glycoproteins (SIBLING), a family of non-collagenous proteins including osteopontin (OPN) and bone sialoprotein (BSP), were ini-tially thought to be limited to mineralized tissue, but recent studies have reported that they are more widely distributed and are expressed in non-mineralized tissues. The aim of this study was to investigate relationships between serum OPN and BSP levels and tendinopathy disease. Method 39 female tendinopathy patients and 39 female healthy volunteers were recruited for this prospective observational study. Serum OPN and BSP levels were measured using enzyme-linked immunosorbent assay. We also measured body mass index and erythrocyte sedimentation rate (ESR), white blood cells (WBC), and neutrophil-lymphocyte ratio (NLR). Results There were no significant differences in serum BSP levels between the two groups (41.83 ± 52.03 vs. 53.64 ± 53.06 ng/mL, p=0.276). There were also no signifi-cant differences in serum OPN levels between the two groups (57.37 ± 21.61 vs. 77.72 ± 72.14 ng/mL, p=0.363). There were no significant differences in WBC, NLR, and ESR values between the two groups (p=0.897, p=0.795, p=0.405, respectively). There was no correlation between serum BSP levels and OPN, WBC, NLR, and ESR levels in the patient group. Patients with ten-dinopathy had a negative correlation between serum OPN levels and NLR levels. Conclusion The results of this study have indicated that BSP and OPN levels are not involved in the pathogenesis of tendinopathy.
- 1 July 2017
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 8 (4) , 270-273
Evaluation of serum levels of osteopontin and bone sialoprotein in female patients with tendinopathy
Aim The pathogenesis of tendinopathy remains unclear. Small integrin-binding ligand N-linked glycoproteins (SIBLING), a family of non-collagenous proteins including osteopontin (OPN) and bone sialoprotein (BSP), were ini-tially thought to be limited to mineralized tissue, but recent studies have reported that they are more widely distributed and are expressed in non-mineralized tissues. The aim of this study was to investigate relationships between serum OPN and BSP levels and tendinopathy disease. Method 39 female tendinopathy patients and 39 female healthy volunteers were recruited for this prospective observational study. Serum OPN and BSP levels were measured using enzyme-linked immunosorbent assay. We also measured body mass index and erythrocyte sedimentation rate (ESR), white blood cells (WBC), and neutrophil-lymphocyte ratio (NLR). Results There were no significant differences in serum BSP levels between the two groups (41.83 ± 52.03 vs. 53.64 ± 53.06 ng/mL, p=0.276). There were also no signifi-cant differences in serum OPN levels between the two groups (57.37 ± 21.61 vs. 77.72 ± 72.14 ng/mL, p=0.363). There were no significant differences in WBC, NLR, and ESR values between the two groups (p=0.897, p=0.795, p=0.405, respectively). There was no correlation between serum BSP levels and OPN, WBC, NLR, and ESR levels in the patient group. Patients with ten-dinopathy had a negative correlation between serum OPN levels and NLR levels. Conclusion The results of this study have indicated that BSP and OPN levels are not involved in the pathogenesis of tendinopathy.
- 18 April 2017
- Published by Wolters Kluwer Health in Neurology
- Vol. 88 (16_supplem)
Efficacy of Peripheral Lidocaine Application (Neural Therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients (P3.366)
- 18 April 2017
- Published by Wolters Kluwer Health in Neurology
- Vol. 88 (16_supplem)
Efficacy of Peripheral Lidocaine Application (Neural Therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients (P3.366)
- Open Access
- 31 March 2017
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 42 (1) , 132
Osteoartrit hastalarında hematolojik parametrelerin tanısal değeri
Amaç: Tam kan sayımı parametreleri, inflamatuar sürecin göstergesi olarak birçok hastalıkta araştırılmıştır. Ancak osteoartrit hastalığındaki rolleri tam olarak anlaşılamamıştır. Bu çalışmanın amacı, osteoartrit hastalığında hematolojik parametrelerin tanısal değerini araştırmak ve klinik önemlerini ortaya koymaktır. Yöntemler: Çalışmaya 118 osteoartrit hastası ile yaş ve cinsiyeti benzer 145 sağlıklı birey dahil edildi. Tıbbi geçmişi, eritrosit sedimentasyon hızı (ESR), C-reaktif protein (CRP), beyaz küre sayısı (WBC), nötrofil-lenfosit oranı (NLR), platelet sayısı (PLT), platelet dağılım genişliği (PDW), kırmızı küre dağılım genişliği (RDW), RDW-platelet oranı (RPR), platelet-lenfosit oranı (PLR) ve ortalama platelet hacmi (MPV) değerleri retrospektif olarak hasta dosyalarından elde edildi. Bulgular: İki grup arasında WBC, RDW, PLT, RPR değerleri arasında fark bulunamamıştır. NLR ve PLR değerleri osteoartrit hastalarında istatistiksel olarak kontrol grubuna göre anlamlı şekilde daha yüksek bulundu. RBC, MPV ve PDW değerleri, osteoartrit hastalarında istatistiksel olarak anlamlı şekilde daha düşük bulundu. Hasta grubunda ESR ve CRP değerleri, MPV ve RBC ile negatif şekilde korelasyon gösterdi. Sonuç: Çalışmamız, hematolojik inflamatuar parametrelerin osteoartrit hastalığında tanısal belirteçler olarak kullanılabileceğini göstermiştir.
- 31 March 2017
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 42 (1) , 132
Open AccessOsteoartrit hastalarında hematolojik parametrelerin tanısal değeri
Amaç: Tam kan sayımı parametreleri, inflamatuar sürecin göstergesi olarak birçok hastalıkta araştırılmıştır. Ancak osteoartrit hastalığındaki rolleri tam olarak anlaşılamamıştır. Bu çalışmanın amacı, osteoartrit hastalığında hematolojik parametrelerin tanısal değerini araştırmak ve klinik önemlerini ortaya koymaktır. Yöntemler: Çalışmaya 118 osteoartrit hastası ile yaş ve cinsiyeti benzer 145 sağlıklı birey dahil edildi. Tıbbi geçmişi, eritrosit sedimentasyon hızı (ESR), C-reaktif protein (CRP), beyaz küre sayısı (WBC), nötrofil-lenfosit oranı (NLR), platelet sayısı (PLT), platelet dağılım genişliği (PDW), kırmızı küre dağılım genişliği (RDW), RDW-platelet oranı (RPR), platelet-lenfosit oranı (PLR) ve ortalama platelet hacmi (MPV) değerleri retrospektif olarak hasta dosyalarından elde edildi. Bulgular: İki grup arasında WBC, RDW, PLT, RPR değerleri arasında fark bulunamamıştır. NLR ve PLR değerleri osteoartrit hastalarında istatistiksel olarak kontrol grubuna göre anlamlı şekilde daha yüksek bulundu. RBC, MPV ve PDW değerleri, osteoartrit hastalarında istatistiksel olarak anlamlı şekilde daha düşük bulundu. Hasta grubunda ESR ve CRP değerleri, MPV ve RBC ile negatif şekilde korelasyon gösterdi. Sonuç: Çalışmamız, hematolojik inflamatuar parametrelerin osteoartrit hastalığında tanısal belirteçler olarak kullanılabileceğini göstermiştir.
- 13 January 2017
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (7) , 1832-1838
Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
Aims Many agents and treatments are used in the treatment of neurogenic detrusor overactivity (NDO) in MS patients, but no study has been conducted on the use of peripheric lidocaine (neural therapy—NT) on MS patients. We evaluated the effects of local administration of lidocaine on NDO in Multiple Sclerosis (MS) patients. Methods For each patient local anesthetic lidocaine was injected at each session. Sessions were held once a week for 5 weeks. At each session, Th 10-L1, urogenital segment intradermal injections, Frankenhauser, and sacral epidural injections were given. The patients had clinical and urodynamic assessment 1 month before and 3, 9, and 12 months after NT. In addition, multiple sclerosis quality of life inventory (MSQL-54) and bladder control scale (BLCS) was performed for patients. Results Twenty-eight patients were included in the study (8 males, 20 females). The patients' average age was 31.7 ± 8.1 years. The injection therapy significantly improved volume at first involuntary bladder contraction (FCV), maximal detrusor pression during filling (P det. max.), maximal cystometric bladder capacity (MCC) after 3 months. Also, the MSQL-54 and BLCS scores were improved with treatment. However, these improvements reached a maximum 3 months after treatment, but from the 9 month a regression was seen in the parameters, and after 12 months the findings were seen to be slightly above their basal levels. Conclusions These results suggest that NDO treatment in MS patients could be an effective treatment which is easy and has very few side effects, and is cost effective.
- 13 January 2017
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (7) , 1832-1838
Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
Aims Many agents and treatments are used in the treatment of neurogenic detrusor overactivity (NDO) in MS patients, but no study has been conducted on the use of peripheric lidocaine (neural therapy—NT) on MS patients. We evaluated the effects of local administration of lidocaine on NDO in Multiple Sclerosis (MS) patients. Methods For each patient local anesthetic lidocaine was injected at each session. Sessions were held once a week for 5 weeks. At each session, Th 10-L1, urogenital segment intradermal injections, Frankenhauser, and sacral epidural injections were given. The patients had clinical and urodynamic assessment 1 month before and 3, 9, and 12 months after NT. In addition, multiple sclerosis quality of life inventory (MSQL-54) and bladder control scale (BLCS) was performed for patients. Results Twenty-eight patients were included in the study (8 males, 20 females). The patients' average age was 31.7 ± 8.1 years. The injection therapy significantly improved volume at first involuntary bladder contraction (FCV), maximal detrusor pression during filling (P det. max.), maximal cystometric bladder capacity (MCC) after 3 months. Also, the MSQL-54 and BLCS scores were improved with treatment. However, these improvements reached a maximum 3 months after treatment, but from the 9 month a regression was seen in the parameters, and after 12 months the findings were seen to be slightly above their basal levels. Conclusions These results suggest that NDO treatment in MS patients could be an effective treatment which is easy and has very few side effects, and is cost effective.